Table 5 Multivariate analysis for variables as predictors for relapse
From: Efficacy of Anti-Thyroid Medications in Patients with Graves’ Disease
Effect | Beta | Standard Error | Odds Ratio | [95% Conf. Interval] | P-value |
|---|---|---|---|---|---|
Free T4 upon diagnosis | 0.0429 | 0.0466 | 1.044 | ( 0.95, 1.14 ) | 0.3576 |
TSH receptor antibodies level up on diagnosis | -0.00888 | 0.0499 | 0.991 | ( 0.90, 1.09 ) | 0.8589 |
Thyroid scan and uptake up on diagnosis | -0.0823 | 0.0524 | 0.921 | ( 0.83, 1.02 ) | 0.1162 |
Gender | -0.7718 | 0.7911 | 0.462 | ( 0.10, 2.18 ) | 0.3293 |
Ophthalmopathy severity(mild versus moderate and sever) | -0.9819 | 1.1014 | 0.375 | ( 0.04, 3.24 ) | 0.3726 |
Age | 0.000938 | 0.0242 | 1.001 | ( 0.95, 1.05 ) | 0.9691 |
Duration of ATDs treatment | -0.0612 | 0.0194 | 0.941 | ( 0.91, 0.98 ) | 0.0016 |